DNAprint Genomics (DNAG)

[SlopsterSlasher]

Pharm-Eco unveils new small manufacturing facility and cryogenic cooling capabilities.

Devens, MA – Pharm-Eco, A Johnson Matthey Company unveiled its two new reactor suites today, signaling the completion of the first phase in their Devens, MA pilot plant expansion as well as the launch of a new capability, cryogenic cooling.

Each 3 floor suite is equipped with three reactors plus its associated auxiliary equipment. Suite A has a 100 gallon glass lined reactor, plus a 200 gallon hastelloy reactor with cryogenic cooling capabilities. Suite B has a 200 and 500 gallon glass lined reactor as well as a 500 gallon hastelloy reactor, also with cryogenic cooling capabilities.

The addition of the suites and cryogenic capabilities to their two existing pilot plants and 32 kilo labs brings a new dynamic to Pharm-Eco’s ability to completely serve a client’s needs by taking a drug from early stage discovery/medicinal chemistry all the way to commercialization. Dr. S.A. Zahr, General Manager and Executive Vice President of Pharm-Eco, thinks the additions are a win-win situation for both Pharm-Eco and their clients.

“Our goal is to enable our clients to succeed in their discovery, development and production of API by getting them to market faster through innovative, cost efficient chemistry services. The addition of the suites is a win-win situation for both us and the clients whose needs we serve. Continued growth as well as integrating our experience, capabilities, facilities, and resources with fellow Johnson Matthey Pharmaceutical Materials Division members and other Johnson Matthey business units, enables us to provide our clients with the complete development solution,” said Zahr.

The building in which the new suites are housed is designed to allow for at least six additional similar reactor suites in the future.